Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine — the nation's only traditional ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

A Department of Health and Human Services spokesperson called the move "a radical departure from past practices." ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...